TFX Stock Analysis: Buy, Sell, or Hold?
TFX - Teleflex Incorporated
$138.83
3.87 (2.87%)
▲
5d:
+1.21%
30d:
+5.85%
90d:
+5.25%
BUY
MODERATE Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When TFX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: TFX shows positive signals but monitor for confirmation. Market pricing in 5.3% growth. Moderate conviction.
💡 BUY OPPORTUNITY: TFX shows positive signals but monitor for confirmation. Market pricing in 5.3% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$226.07
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$140.37
1.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TFX is currently trading at $138.83, which is considered extended relative to its 30-day fair value range of $132.23 to $137.45. From a valuation perspective, the stock is trading at a premium (Forward PE: 12.3) compared to its historical average (10.6). At these levels, the market is pricing in 5.3% annual earnings growth.
Technical Outlook: Technically, TFX is in a uptrend. The price is approaching resistance at $139.21. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TFX scores 67/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (23th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $152.55 (+13.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TFX is in a uptrend. The price is approaching resistance at $139.21. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TFX scores 67/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (23th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $152.55 (+13.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$132.23 -
$137.45
Company Quality Score
60/100
(HOLD)
Options IV Signal
23th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
70.0%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 23th percentile)
- BULLISH: Strong technical setup (67/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($152.55)
- BULLISH: Expecting earnings turnaround to 5.3% growth with 28.9% revenue growth
- BULLISH: Bottoming setup score 67/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$132.23 -
$137.45
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$7.29
(5.3%)
Support & Resistance Levels
Support Level
$130.89
Resistance Level
$139.21
Current Trend
Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.32
Wall Street Target
$152.55
(+13.0%)
Revenue Growth (YoY)
28.9%
Earnings Growth (YoY)
-17.3%
Profit Margin
-45.8%
Valuation Premium vs History
+5.3% premium
PE vs Historical
12.3 vs 10.6
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.3%
(market-implied from PE analysis)
1-Year Target
$142.11
(+5%)
2-Year Target
$149.64
(+11%)
3-Year Target
$157.58
(+17%)
3-Yr Target (if PE normalizes)
(PE: 12→11)
PE COMPRESSION
$135.54
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 54.8%)
$741.84
(+450%)
Base:
(SPY PE: 12.3, Growth: 54.8%)
$455.49
(+238%)
Bear:
(PE: 10.5, Growth: 54.8%)
$387.17
(+187%)
Share & Embed Analysis
Last updated: August 22, 2026 12:40 PM ET
Data refreshes hourly during market hours. Next update: 1:40 PM
Data refreshes hourly during market hours. Next update: 1:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TFX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 46 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$86 | 37 SELL |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$405 | 66 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 45 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$247 | 41 HOLD |
Advanced TFX Option Strategies
Professional options setups generated by AI based on today's TFX price and gamma walls.
